Beilinson Campus

May 9, 2024 | bmcpulmmed.biomedcentral.com | Beilinson Campus |Sackler Faculty |Petach Tikva

We conducted a single-center, prospective, single-blinded, randomized, placebo-controlled trial at Rabin Medical Center in Israel between November 2019 and January 2023. The first patient was recruited on 03/11/2019, and the last patient was recruited on 15/01/2023.

Apr 17, 2024 | link.springer.com | Beilinson Campus |Petah Tikva |Bioinformatics Unit

AbstractDistal Xq28 duplication, or int22h1/int22h2-mediated Xq28 duplication syndrome, leads to cognitive impairment, neurobehavioral issues, and facial dysmorphisms. Existing literature has limited information on clinical traits and penetrance.

Nov 16, 2023 | ashpublications.org | Petach Tikva |Ben Gurion |Beilinson Campus

Citation Ruth ShilohRuth LubinOdeya DavidIfat GeronElimelech OkonIdit HazanMarketa ZaliovaGil AmarilyoYehudit BirgerYael BorovitzDafna BrikArnon BroidesSarit Cohen-KedarLiora HarelEyal KristalDaria KozlovaGalina LingMika Shapira RootmanNoa Shefer AverbuchShiri SpielmanJan TrkaShai IzraeliSimon YonaSarah Elitzur; Loss of function of ENT3 drives histiocytosis and inflammation through TLR-MAPK signaling. Blood 2023; 142 (20): 1740–1751.